These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
734 related articles for article (PubMed ID: 28599652)
1. Regulatory T cells in multiple sclerosis and myasthenia gravis. Danikowski KM; Jayaraman S; Prabhakar BS J Neuroinflammation; 2017 Jun; 14(1):117. PubMed ID: 28599652 [TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells. Aricha R; Reuveni D; Fuchs S; Souroujon MC J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998 [TBL] [Abstract][Full Text] [Related]
3. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys. Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557 [TBL] [Abstract][Full Text] [Related]
4. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines. Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702 [TBL] [Abstract][Full Text] [Related]
5. Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model. Gertel-Lapter S; Mizrachi K; Berrih-Aknin S; Fuchs S; Souroujon MC Autoimmun Rev; 2013 Jul; 12(9):894-903. PubMed ID: 23535156 [TBL] [Abstract][Full Text] [Related]
6. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells. Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756 [TBL] [Abstract][Full Text] [Related]
7. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis. Aricha R; Feferman T; Fuchs S; Souroujon MC J Immunol; 2008 Feb; 180(4):2132-9. PubMed ID: 18250419 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis. Chae CS; Kwon HK; Hwang JS; Kim JE; Im SH PLoS One; 2012; 7(12):e52119. PubMed ID: 23284891 [TBL] [Abstract][Full Text] [Related]
9. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385 [TBL] [Abstract][Full Text] [Related]
12. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia. Liu R; La Cava A; Bai XF; Jee Y; Price M; Campagnolo DI; Christadoss P; Vollmer TL; Van Kaer L; Shi FD J Immunol; 2005 Dec; 175(12):7898-904. PubMed ID: 16339525 [TBL] [Abstract][Full Text] [Related]
13. Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis. Souroujon MC; Aricha R; Feferman T; Mizrachi K; Reuveni D; Fuchs S Ann N Y Acad Sci; 2012 Dec; 1274():120-6. PubMed ID: 23252906 [TBL] [Abstract][Full Text] [Related]
15. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707 [TBL] [Abstract][Full Text] [Related]
16. The role of regulatory T Cells in autoimmune orchitis. Jacobo P Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653 [TBL] [Abstract][Full Text] [Related]
17. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis. Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998 [TBL] [Abstract][Full Text] [Related]
18. An angel or a devil? Current view on the role of CD8 Peng Y; Yang H; Chen Q; Jin H; Xue YH; Du MQ; Liu S; Yao SY J Transl Med; 2024 Feb; 22(1):183. PubMed ID: 38378668 [TBL] [Abstract][Full Text] [Related]
19. Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia. Liu R; Zhou Q; La Cava A; Campagnolo DI; Van Kaer L; Shi FD Eur J Immunol; 2010 Jun; 40(6):1577-89. PubMed ID: 20352624 [TBL] [Abstract][Full Text] [Related]
20. A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats Song J; Zhao R; Yan C; Luo S; Xi J; Ding P; Li L; Hu W; Zhao C Front Immunol; 2022; 13():746068. PubMed ID: 35154091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]